Elevated PAPP-A sets alarm bells ringing in patients with cardiac chest pain

References

• Anderson JL, Adams CD, Antman EM et al. ACC/AHA guidelines for the management of patients with unstable angina/non–STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non–ST-Elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J. Am. Coll. Cardiol. 50, e1–e157 (2007).
   Google Scholar
• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European society of cardiology/American College of cardiology committee for redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36, 959–69 (2000).
   PubMed Web of Science ®Google Scholar
• von Haehling S, Papassotiriou J, Hartmann O et al. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease. Clin. Sci. (Lond.) 123, 601–610 (2012).
   Google Scholar
• von Haehling S, Jankowska EA, Morgenthaler NG et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J. Am. Coll. Cardiol. 50, 1973–1980 (2007).
   PubMed Web of Science ®Google Scholar
• von Haehling S, Papassotiriou J, Morgenthaler NG et al. Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. Int. J. Cardiol. 162, 27–32 (2012).
   Web of Science ®Google Scholar
• Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler. Thromb. Vasc. Biol. 27, 15–26 (2007).
   PubMed Web of Science ®Google Scholar
• Shah PK. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41, 15S–22S (2003).
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355–1374 (1995).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, Conover CA, Overgaard MT et al. Pregnancy associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 345, 1022–1029 (2001).
   Google Scholar
• Iversen K, Teisner A, Dalager S, Olsen KE, Floridon C, Teisner B. Pregnancy-associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque. Clin. Biochem. 44, 312–318 (2011).
   PubMed Web of Science ®Google Scholar
• Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol. Metab. 14, 176–181 (2003).
   PubMed Web of Science ®Google Scholar
• Conti E, Andreotti F, Zuppi C. Pregnancy-associated plasma protein a as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 109, e211–e212 (2004).
   Google Scholar
• von Haehling S, Doehner W, Jankowska EA et al. Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain. CMAJ 185, E295–E303 (2013).
   Google Scholar
• Iversen KK, Dalsgaard M, Teisner AS et al. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. Am. J. Cardiol. 104, 1465–1471 (2009).
   PubMed Web of Science ®Google Scholar
• Cosin-Sales J, Christiansen M, Kaminski P et al. Pregnancy associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109, 1724–1728 (2004).
   PubMed Web of Science ®Google Scholar
• Elesber AA, Conover CA, Denktas AE et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur. Heart J. 27, 1678–1684 (2006).
   PubMed Web of Science ®Google Scholar
• Heeschen C, Dimmeler S, Hamm CW et al. CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 45, 229–237 (2005).
   PubMed Web of Science ®Google Scholar
• Cosin-Sales J, Kaski JC, Christiansen M et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur. Heart J. 26, 2093–2098 (2005).
   Google Scholar
• Schaub N, Reichlin T, Meune C et al. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin. Chem. 58, 246–256 (2012).
   PubMed Web of Science ®Google Scholar
• Mjelva OR, Brügger-Andersen T, Pönitz V et al. Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scand. Cardiovasc. J. 47, 88–97 (2013).
   PubMed Web of Science ®Google Scholar
• Zaninotto M, Mion MM, Novello E, Altinier S, Plebani M. New biochemical markers: from bench to bedside. Clin. Chim. Acta. 381, 14–20 (2007).
   Google Scholar
• Qin QP, Kokkala S, Lund J et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin. Chem. 52, 398–404 (2006).
   PubMedGoogle Scholar
• Barrett SL, Bower C, Hadlow NC. Use of the combined first trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat. Diagn. 28, 28–35 (2008).
   PubMed Web of Science ®Google Scholar
• Hájek P, Macek M Sr, Lashkevich A et al. Influence of concomitant heparin administration on pregnancy-associated plasma protein-A levels in acute coronary syndrome with ST segment elevation. Arch. Med. Sci. 7, 977–983 (2011).
   Google Scholar